EHC Encompass Health Corporation

NYSE · US · Healthcare · Medical Care Facilities · encompasshealth.com

120.97USD+0.98%Mkt Cap: 11.93B $P/E: 20.231d ago

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis …

Industry Peers

Medical Care Facilities

Fresenius SE & Co. KGaA

$26.85BUSDP/E 15.8

THC

Tenet Healthcare Corporation

$20.89BUSDP/E 10.0

FME

Fresenius Medical Care AG

$11.75BUSDP/E 12.1

FMS

Fresenius Medical Care AG

Universal Health Services, Inc.

$10.38BUSDP/E 7.2

ENSG

The Ensign Group, Inc.

LifeStance Health Group, Inc.

$4.65BUSDP/E 94.0

CON

Concentra Group Holdings Parent, Inc.

National HealthCare Corporation

$3.61BUSDP/E 25.9

OPCH

Option Care Health, Inc.

$3.50BUSDP/E 17.7

AVAH

Aveanna Healthcare Holdings Inc.

$2.70BUSDP/E 9.8

ACHC

Acadia Healthcare Company, Inc.

$2.69BUSD

GRDN

Guardian Pharmacy Services, Inc.

$2.67BUSDP/E 40.9

BKD

Brookdale Senior Living Inc.

$2.51BUSD

Pediatrix Medical Group, Inc.

$2.12BUSDP/E 12.5

Key Statistics

Company

Market Cap11.93B USD

Enterprise Value15.42B USD

Revenue (TTM)6.21B USD

Gross Profit5.68B USD

Net Income (TTM)566.20M USD

Revenue/Share62.25 USD

Last Price120.97 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees29.7K

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)20.23

P/E (Forward)17.94

PEG0.41

EV/EBITDA10.53

EV/Revenue2.48

P/S1.90

P/B4.56

EPS (TTM)5.98

EPS (Forward)6.68

52W Range

92.7780% of range127.99

52W High127.99 USD

52W Low92.77 USD

Profitability

Gross Margin95.71%

Oper. Margin18.05%

EBITDA Margin23.58%

Profit Margin9.54%

ROE23.22%

ROA7.99%

Growth

Revenue Growth9.60%

Earnings Growth10.80%

Cash Flow & Leverage

Operating CF1.18B USD

CapEx (TTM)736.40M USD

FCF Margin3.70%

FCF Yield1.93%

Net Debt2.73B USD

Net Debt/EBITDA1.87

Balance Sheet

Debt/Equity1.11

Current Ratio1.19

Quick Ratio0.91

Book Value/Sh26.29 USD

Cash/Share1.09 USD

Dividends

Fwd Div Rate0.84 USD

Trail. Div Rate0.76 USD

Div. Yield0.70%

5Y Avg Yield0.86%

Payout Ratio12.71%

Ex-Div DateOct 1, 2026

Pay DateOct 15, 2026

Splits

Last Split1257:1000

Split DateJul 1, 2022

Analyst Consensus

Rating1.1 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)148.17 USD

Upside (mean)+22.5%

Target Range140.00 USD – 155.00 USD

140.00+22.5% to mean155.00

# Analysts12

Ownership

Shares Out.98.65M

Float97.65M

Insiders0.87%

Institutions100.92%

Short Interest

Short Ratio3.7d

Short % Float3.43%

Short % Out.3.04%

Shares Short3.00M

Short (prev mo.)3.27M

Technical

SMA 50120.42 (+0.5%)

SMA 200108.18 (+11.8%)

Beta0.61

S&P 52W Chg14.58%

Avg Vol (30d)862.85K

Avg Vol (10d)984.05K

Technical Indicators

RSI (14)49.1

MACD0.2638

MACD Signal0.7502

MACD Hist.-0.4864

BB Upper124.59 USD

BB Middle121.95 USD

BB Lower119.31 USD

BB Width4.33%

ATR (14)2.892 USD

Vol Ratio (20d)1.15x